Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Modifying steroidal inhibitors shows promise for developing new cancer treatments.

Microneedling combined with triamcinolone can safely stimulate faster hair regrowth in people with Alopecia Areata.

Cannabinoid and steroid-based drugs could be new treatments for Tourette syndrome, but more research is needed to confirm their effectiveness and safety.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

Use lower concentrations of triamcinolone acetonide to reduce steroid-induced scalp atrophy.

Setipiprant did not significantly improve hair growth in men with hair loss.

The model successfully predicted new uses for existing drugs, like using certain hormonal and heart medications for respiratory and Parkinson's diseases, and a cancer drug for diabetes.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Trichostatin A helps restore hair-growing ability in skin cells used for hair regeneration.

Botulinum toxin A can help improve thin endometrium and embryo implantation.

N-acetylcysteine and memantine are recommended as safe and effective treatments for trichotillomania.

The Drug Ontology was updated to better classify drugs for hypertension, malaria, and opioid abuse, and to allow for more accurate research queries.

Intralesional triamcinolone is more effective than cryotherapy for treating alopecia areata in middle-aged adults.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.

Ruxolitinib can help regrow hair in severe alopecia areata.

Properly administered testosterone therapy is safe and effective but often not covered by insurance.

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

Polydopamine is promising for personalized medicine and biomedical technology due to its strong adhesion and biocompatibility.

Proteins from Tianshan red deer abomasum have strong anti-inflammatory, anti-tumor, and antioxidant effects.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

GLP-1 receptor agonists increase the risk of hair loss, mainly due to weight loss-related nutrient deficiency.

Suppressing ODC activity reduces tumor growth in hair follicles.

MEK and BRAF inhibitors increase sebum production and accumulation, which could cause acne-like side effects.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Combining triamcinolone acetonide with cryotherapy may reduce scalp hair loss more than using triamcinolone alone.

Tracnil™, a mix of myo-inositol, folic acid, and vitamin D3, safely reduced acne, improved excessive hair growth, and fixed irregular periods in overweight women with PCOS.

Baricitinib shows promise for treating alopecia areata with mild side effects.

Ritlecitinib is safe and may effectively treat alopecia areata.